Keisho Chìn

Japanese Foundation For Cancer Research ORCID: 0000-0002-2015-8185

2

h-index

2

Publications

2,427

Citations

Publications

2 shown

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara , Mustafa Özgüroğlu , Yung‐Jue Bang +97 more

2018 The Lancet 1262 citations

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ioannis Xynos , Mamoru Kodani , Yuko Kitagawa +15 more

2019 The Lancet Oncology 1165 citations

Frequent Co-Authors

Kohei Shitara

National Cancer Center Hospital East

Mustafa Özgüroğlu

Florida Hospital Cancer Institute

Yung‐Jue Bang

Seoul National University

Maria Di Bartolomeo

Fondazione IRCCS Istituto Nazionale dei Tumori

Mario Mandalà

Ospedale Papa Giovanni XXIII

Min‐Hee Ryu

Asan Medical Center

Researcher Info

h-index: 2
Publications: 2
Citations: 2,427
Institution: Japanese Foundation For Cancer Research

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-2015-8185

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.